Literature DB >> 18704357

[Cholinesterase inhibitors for the treatment of dementia in Parkinson's disease].

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18704357     DOI： 10.1007/s00115-008-2544-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  4 in total

Review 1.  Cholinesterase inhibitors for Parkinson's disease dementia.

Authors:  I Maidment; C Fox; M Boustani
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

2.  Rivastigmine for dementia associated with Parkinson's disease.

Authors:  Murat Emre; Dag Aarsland; Alberto Albanese; E Jane Byrne; Günther Deuschl; Peter P De Deyn; Franck Durif; Jaime Kulisevsky; Teus van Laar; Andrew Lees; Werner Poewe; Alain Robillard; Mario M Rosa; Erik Wolters; Peter Quarg; Sibel Tekin; Roger Lane
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

3.  Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  J M Miyasaki; K Shannon; V Voon; B Ravina; G Kleiner-Fisman; K Anderson; L M Shulman; G Gronseth; W J Weiner
Journal:  Neurology       Date:  2006-04-11       Impact factor: 9.910

Review 4.  Cholinesterase inhibitors for dementia with Lewy bodies.

Authors:  R Wild; T Pettit; A Burns
Journal:  Cochrane Database Syst Rev       Date:  2003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.